Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tropea

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Neurology|February 17, 2021
Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body DementiasErica Howard, David J Irwin, Katya Rascovsky, et al.
Neurology|March 6, 2024
Disparities in Genetic Testing for Neurologic DisordersAaron Baldwin, Juliette Copeland, Meron Azage, et al.
Journal of Neurology|October 27, 2023
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsLaynie Dratch, Meron Azage, Aaron Baldwin, et al.
Science (New York, N.Y.)|August 18, 2022
GPNMB confers risk for Parkinson's disease through interaction with α-synucleinMaria E Diaz-Ortiz, Yunji Seo, Marijan Posavi, et al.
Annals of Clinical and Translational Neurology|April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined SynucleinopathyDaniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Annals of Neurology|May 11, 2026
Recruitment Strategies across the Spectrum of Neuronal Synuclein DiseaseAndrew Siderowf, Laura E A Heathers, Kimberly Fabrizio, et al.
Neurology|February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseKatheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
NPJ Parkinson'S Disease|May 3, 2024
Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide levelThomas F Tropea, Whitney Hartstone, Noor Amari, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Novel <i>PCDH12</i> pathogenic missense variants cause neurodevelopmental disorders with ocular malformationJennifer Rakotomamonjy, Lucas Fares-Taie, Raman Kumar, et al.
The Lancet. Neurology|November 22, 2024
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort studyYihua Ma, Carly M Farris, Sandrina Weber, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Neurology|February 17, 2021
Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body DementiasErica Howard, David J Irwin, Katya Rascovsky, et al.
Neurology|March 6, 2024
Disparities in Genetic Testing for Neurologic DisordersAaron Baldwin, Juliette Copeland, Meron Azage, et al.
Journal of Neurology|October 27, 2023
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsLaynie Dratch, Meron Azage, Aaron Baldwin, et al.
Science (New York, N.Y.)|August 18, 2022
GPNMB confers risk for Parkinson's disease through interaction with α-synucleinMaria E Diaz-Ortiz, Yunji Seo, Marijan Posavi, et al.
Annals of Clinical and Translational Neurology|April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined SynucleinopathyDaniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Annals of Neurology|May 11, 2026
Recruitment Strategies across the Spectrum of Neuronal Synuclein DiseaseAndrew Siderowf, Laura E A Heathers, Kimberly Fabrizio, et al.
Neurology|February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseKatheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
NPJ Parkinson'S Disease|May 3, 2024
Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide levelThomas F Tropea, Whitney Hartstone, Noor Amari, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Novel <i>PCDH12</i> pathogenic missense variants cause neurodevelopmental disorders with ocular malformationJennifer Rakotomamonjy, Lucas Fares-Taie, Raman Kumar, et al.
The Lancet. Neurology|November 22, 2024
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort studyYihua Ma, Carly M Farris, Sandrina Weber, et al.
Pageof 12